Published in Ter Arkh on January 01, 1998
Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost (1999) 1.31
[Changes of platelet aggregation in cancer patients]. Vopr Onkol (2007) 0.80
[Severe eosinophilia in a patient with the inhibitory form of hemophilia B]. Ter Arkh (1970) 0.77
[The specific features of respiratory support in patients with obstructive sleep apnoea syndrome concurrent with chronic obstructive pulmonary disease (crossing-syndrome)]. Ter Arkh (2010) 0.77
[Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia]. Angiol Sosud Khir (2007) 0.77
[Methods for diagnosis of thrombophilia caused by disorders in the protein C system (comments on publications by A L Berkovskiĭ et al.)]. Klin Lab Diagn (2002) 0.75
[2 new forms of combined hereditary hemorrhagic diatheses]. Ter Arkh (1968) 0.75
[Trials of a method for assessing thromboplastic activity of monocytes in the newborn]. Klin Lab Diagn (1995) 0.75
[Recognition of the disseminated intravascular coagulation syndrome: methodology and expert assessment]. Lab Delo (1989) 0.75
[Significance of the determination of B2-glycoprotein-1 antibodies in recognizing the thrombogenicity in antiphospholipid syndrome]. Klin Lab Diagn (2008) 0.75
[The ability of low-molecular heparin (Fraxiparin) to overcome the action of exogenous coagulases--a fundamental difference from nonfractionated heparin]. Biull Eksp Biol Med (1993) 0.75
[Improvement in the effectiveness of detection of lupus type anticoagulants by Echis toxin tests]. Klin Lab Diagn (1995) 0.75
[The pathogenesis and therapy of hemostatic disorders in cancer patients]. Ter Arkh (1997) 0.75
[Hemostatic disorders in patients with dysplastic scoliosis]. Gematol Transfuziol (1995) 0.75
[Substantiation, tactics and effectiveness of frozen plasma-enzyme inhibitor therapy in septicemia and infectious-destructive processes]. Gematol Transfuziol (1989) 0.75
[Protein C deficiency and the multi-thrombotic syndrome associated ith pregnancy and abortion]. Gematol Transfuziol (1993) 0.75
[Treatment of patients suffering from hemophilia with stenosing hemorrhages into the region of the upper respiratory tract]. Vestn Otorinolaringol (1972) 0.75
[Primary thrombophilia caused by antithrombin III deficiency]. Ter Arkh (1978) 0.75
[Characteristics of the diagnosis, clinical aspects and treatment of hemophilias with specific, circulating anticoagulants]. Probl Gematol Pereliv Krovi (1972) 0.75
[Current views on the process of blood coagulation, fibrinolysis and the action of natural anticoagulants]. Gematol Transfuziol (1991) 0.75
[Relationship of effective treatment of inflammatory destructive diseases with microcirculatory deblockage in the diseased organs]. Vestn Ross Akad Med Nauk (2000) 0.75
[Hematuric syndrome in hemophilia--characteristics of its development, clinical course and therapy]. Ter Arkh (1974) 0.75
[Mechanisms of heparin resistance and their clinical significance]. Ter Arkh (1982) 0.75
[Experience in the use of apheresis-psoralen-ultraviolet therapy in lympholeukemia and immune diseases]. Gematol Transfuziol (1991) 0.75
[Determination of heparin in blood]. Lab Delo (1971) 0.75
Toxinology papers at the fourth all-union conference of Soviet herpetologists. Toxicon (1978) 0.75
[Hemophilia and nosebleed]. Vestn Otorinolaringol (1976) 0.75
[Scanning electron microscopic examination of platelet morphology]. Lab Delo (1982) 0.75
[Certain aspects of therapy and prevention of joint involvement in hemophilia]. Ter Arkh (1981) 0.75
[Basic aspects of the conservative therapy of hemophilic joint diseases]. Ter Arkh (1971) 0.75
[Comparative analysis of various methods of determination of fibrinogen in the plasma]. Klin Lab Diagn (1997) 0.75
[Bleeding from the upper respiratory tract in Glanzmann's thrombopenia]. Vestn Otorinolaringol (1981) 0.75
[Autohemotransfusion in lung surgery]. Grudn Khir (1970) 0.75
[Antiphospholipid syndrome and resistance to replacement therapy in hemophilia]. Klin Med (Mosk) (1992) 0.75
[Clinical significance and problems of treatment of patients with heparin-induced thrombocytopenia]. Ter Arkh (1999) 0.75
[Diagnostic procedure for thrombophilia due to factor VIII hyperproduction]. Klin Lab Diagn (2007) 0.75
[Plasmapheresis in combined treatment of severe forms of abscesses and gangrene of the lungs]. Klin Med (Mosk) (1989) 0.75
[Progressively acting antithrombins and plasma heparin resistance in ischemic heart disease]. Kardiologiia (1981) 0.75
[The role of the radionuclide study method in the diagnosis and therapy of hemophilic joint lesions]. Ter Arkh (1992) 0.75
[General principles of research on the hemostatic system and analysis of new methods for detecting intravascular blood coagulation]. Ter Arkh (1988) 0.75
[Wide-spectrum effects of lupus anticoagulant in a patient with complex immunopathologic processes]. Gematol Transfuziol (1989) 0.75
[Changes in the composition and properties of the joint contents in hemophilic arthropathies during local invasive therapy]. Ter Arkh (1994) 0.75
[The clinical characteristics, complications and therapeutic problems of protein C deficiency]. Ter Arkh (1993) 0.75
[Experience in the use of staged plasmapheresis for preventing fetal loss in women with lupus-type anticoagulants circulating in their blood]. Ter Arkh (1989) 0.75
[Combined 2d-type TAR syndrome, factor X deficiency, immune deficiency and mitral valve prolapse]. Ter Arkh (1986) 0.75
[The clinical significance of a combination of dysplastic scoliosis with hemostatic system disorders]. Klin Khir (1994) 0.75
[Hematogenic thrombophilia]. Ter Arkh (1983) 0.75
[The principles of the laboratory diagnosis of the antiphospholipid syndrome]. Klin Lab Diagn (2000) 0.75
[Neuritic bleeding and undiscovered mechanisms of regulation of the hemostasis system]. Ter Arkh (2001) 0.75
[Complex intensive therapy of terminal disseminated intravascular coagulation and thromboembolic syndrome in Marchiafava-Micheli anemia]. Gematol Transfuziol (1987) 0.75
[Thrombogenic shifts in thrombocyte hemostasis and blood coagulability in frostbite]. Sov Med (1976) 0.75
[Effect of protamine sulfate on experimental acute toxigenic DIC syndrome]. Gematol Transfuziol (1988) 0.75
[Methodology, interpretation and clinical value of the Staphylococcus agglutination test]. Lab Delo (1988) 0.75
[The use of fraxiparin for the prevention and treatment of thromboembolism in patients with heparin-induced thrombocytopenia]. Ter Arkh (1993) 0.75
[Dynamics of qualitative and quantitative erythrocyte changes during the development of toxigenic syndromes of disseminated intravascular coagulation]. Gematol Transfuziol (1988) 0.75
[Biochemical characteristics of liver involvement in patients with antiphospholipid syndrome]. Klin Lab Diagn (2000) 0.75
[Physiological anticoagulants. Current data on the composition, function and clinical value]. Lab Delo (1978) 0.75
[Restoration of the microcirculation in the treatment of acute destructive lung diseases]. Klin Med (Mosk) (1988) 0.75
[Assessment of the degree of damage to erythrocytes in disseminated intravascular blood coagulation]. Lab Delo (1988) 0.75
[A new method for determination of antithrombin III and its diagnostic significance]. Klin Lab Diagn (2004) 0.75
[Laboratory monitoring of recombinant factor VIIA effects]. Klin Lab Diagn (2007) 0.75
Shape and spreading of platelets from the blood of patients with acute myocardial infarction. Thromb Haemost (1984) 0.75
[Activation of factor VII as a global marker of thrombophilic conditions]. Kardiologiia (1989) 0.75
[The significance of thromboelastography in obliterating diseases of the arteries of the extremities]. Khirurgiia (Mosk) (1969) 0.75
[Effect of heparin on fibrinogen formation during experimental toxic syndrome of disseminated intravascular coagulation]. Ukr Biokhim Zh (1978) (1988) 0.75
[Prevalence, diagnosis and clinical significance of thrombophilia caused by Va factor resistance to activated C protein]. Vestn Ross Akad Med Nauk (1997) 0.75
[Cryoplasmic-antienzyme therapy in infectious destructive diseases of the lungs]. Ter Arkh (1987) 0.75
[Disorders of the hemostasis system in patients with mitral valve prolapse]. Klin Med (Mosk) (1994) 0.75
[Recognition, express diagnosis and classification of thrombocytopathies today]. Probl Gematol Pereliv Krovi (1979) 0.75
[Use of equipment for external fixation and rehabilitation of patients with hemophilia]. Gematol Transfuziol (1989) 0.75
[Function of the thrombocytes and recurrent nasal hemorrhage of unclear genesis]. Vestn Otorinolaringol (1976) 0.75
[Primary disaggregational thrombocytopathies]. Probl Gematol Pereliv Krovi (1975) 0.75
[Etiology and interrelation of recurrent nosebleeds and uterine hemorrhages]. Vestn Otorinolaringol (1977) 0.75
[Effect of heparin on erythrocyte damage in various toxicogenic DIC syndromes]. Gematol Transfuziol (1990) 0.75
[Clinical course and treatment of mediastinal thymomas]. Grudn Khir (1969) 0.75
[Use of elimination of plasma phospholipid membranes for detection of "lupus anticoagulant" effects]. Klin Lab Diagn (1997) 0.75
[Comparative study of characteristics in the development of different toxigenic syndromes of disseminated intravascular blood coagulation]. Patol Fiziol Eksp Ter (1988) 0.75
[An unified method of one-stage quantitative analysis of factors VIII and IX. I. (Results of the studies of the working group of the All-Union Problem-Solving Commission on "Pathology of hemostasis")]. Gematol Transfuziol (1991) 0.75
[From a patient to discovery: a conventional approach to detection of unknown diseases and components of the biological systems]. Ter Arkh (2004) 0.75
[The problem of surgical treatment of hemophilia patients with specific circulating inhibitors of blood clotting]. Probl Gematol Pereliv Krovi (1971) 0.75
[The importance of studying the joint contents in diagnosing secondary immune disorders and in assessing therapeutic efficacy in hemophilic arthropathies]. Ter Arkh (1994) 0.75
[Principles of the diagnosis and classification of thrombocytopathies]. Probl Gematol Pereliv Krovi (1974) 0.75
[Thrombophilia characterized by resistance to anticoagulants with indirect action]. Ter Arkh (1995) 0.75
[Hemorrhage from the upper respiratory tract and Willebrand's disease]. Vestn Otorinolaringol (1979) 0.75
[Stimulation of the release of factor VIII and von Willebrand factor into the plasma of donors and the cryoprecipitate]. Gematol Transfuziol (1993) 0.75
[Disorders in the blood coagulation of patients with mesenchymal dysplasias]. Gematol Transfuziol (1993) 0.75
[In memoriam Prof. Petr Pavlovich Perfil'ev (1897-1977)]. Med Parazitol (Mosk) (1979) 0.75
[Current problems of diagnosis and pathogenetic therapy of disseminated intravascular coagulation]. Ter Arkh (1979) 0.75
[The advisability of modifying the current outline of blood coagulation]. Ter Arkh (1990) 0.75
[Methods and clinical significance of paracoagulation phenanthroline test]n. Klin Lab Diagn (1996) 0.75
[Methods of detection and ambulatory treatment of hemorrhagic diathesis]. Ter Arkh (1975) 0.75
Rheumatoid factor and secondary rheumatoid disturbances in patients with haemophilia. Vox Sang (1987) 0.75
[Is it advisable to inject novocaine solution intra-articularly during invasive therapy of hemarthrosis in patients with hemophilia?]. Gematol Transfuziol (1993) 0.75
[Characteristics of microcirculatory hemostasis based on data of aspirin tolerance test in patients with chronic tonsillitis]. Vestn Otorinolaringol (1970) 0.75
[Effect of bronchography with an aqueous barium suspension on the pulmonary tissue]. Grudn Khir (1972) 0.75
[Initial experience in the diagnosis of thrombophilia due to activated protein C resistance]. Ter Arkh (1997) 0.75
[Comparative analysis of unfractionated and low molecular weight heparins on the polymerization process of fibrin]. Biull Eksp Biol Med (1997) 0.75
[Abortion and fetal death in disorders of the hemostasis system]. Gematol Transfuziol (1991) 0.75
[A method for determining plasminogen with a Russian chromogenic substrate and its diagnostic significance]. Klin Lab Diagn (2000) 0.75
[Comparative assessment of the effectiveness of auto- and homohemotransfusion in experimental hemorrhagic shock]. Eksp Khir Anesteziol (1972) 0.75